Metraipolis › archive › dc_4e91ca3b2fce

Impact of Sacubitril/Valsartan on Cardiac Reverse Remodeling in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy — Europe PMC PMID:41590222

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41590222
DOI
10.3390/diseases14010006
License (as archived)
solo-consultazione
Archived
2026-11-07T09:19:04.838Z
SHA-256 of the archived text
1d0578f53ea594830e11a607ec5a7e3db3ccf67677635f5911886acfb71cb3c9
Stable URL of this page
https://metraipolis.com/documento/dc_4e91ca3b2fce

How to cite

Impact of Sacubitril/Valsartan on Cardiac Reverse Remodeling in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy — Europe PMC PMID:41590222 — Europe PMC (en), https://europepmc.org/article/MED/41590222 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e91ca3b2fce (Metraipolis archive dc_4e91ca3b2fce, sha256 1d0578f53ea594830e11a607ec5a7e3db3ccf67677635f5911886acfb71cb3c9)
BibTeX
@misc{dc4e91ca3b2fce,
  title = {Impact of Sacubitril/Valsartan on Cardiac Reverse Remodeling in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy — Europe PMC PMID:41590222},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41590222},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e91ca3b2fce; sha256 1d0578f53ea594830e11a607ec5a7e3db3ccf67677635f5911886acfb71cb3c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41590222. Agents can read the archived copy with the MCP tool read_document.